Journal article

Targeting the Progression of Parkinson's Disease

JL George, S Mok, D Moses, S Wilkins, AI Bush, RA Cherny, DI Finkelstein

CURRENT NEUROPHARMACOLOGY | BENTHAM SCIENCE PUBL LTD | Published : 2009

Abstract

By the time a patient first presents with symptoms of Parkinson's disease at the clinic, a significant proportion (50-70%) of the cells in the substantia nigra (SN) has already been destroyed. This degeneration progresses until, within a few years, most of the cells have died. Except for rare cases of familial PD, the initial trigger for cell loss is unknown. However, we do have some clues as to why the damage, once initiated, progresses unabated. It would represent a major advance in therapy to arrest cell loss at the stage when the patient first presents at the clinic. Current therapies for Parkinson's disease focus on relieving the motor symptoms of the disease, these unfortunately lose t..

View full abstract